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Comment: Thrombosis is the endpoint of atherosclerosis and inflam-
mation is linked to the development of atherosclerosis. This study suggests
that CD40-CD40L interactions may be one molecular mechanism linking
the inflammation and the thrombosis associated with atherosclerosis.
Acute intramural hematoma of the aorta: A mystery in evolution
Evangelista A, Mukherjee D, Mehta RH, and the International Registry of
Aortic Dissection (IRAD) Investigators. Circulation 2005;111:1063-70.
Conclusion: There is a 5-7% prevalence of intramural hematoma
(IMH) in patients with acute aortic syndromes with 16% of patients evolving
to classic aortic dissection (AD) on subsequent imaging studies and a 40%
mortality rate of ascending aorta IMH.
Summary: Acute aortic syndromes are characterized by a sudden onset
of thoracic pain and consist of both classic AD and intramural aortic
hemorrhage. There is an incomplete knowledge of the natural history of
IMH. The International Registry of Aortic Dissection (IRAD) involves
eighteen referral centers in six countries. Potential patients for inclusion in
IRAD are identified prospectively or retrospectively by searching hospital
discharge records. Diagnosis of acute aortic syndrome is suspected on
history and physical examination and confirmed by imaging study or surgical
exploration or post mortem examination.
The current study represents 1,1010 patients enrolled between January
1, 1996 and November 19, 2001. Fifty-eight (5.7%) of patients had IMH.
Patients with IMH tended to be older (68.7 years) than those with classic
AD (61.7 years, P  0.001). Patients with IMH were also more likely to
have distal aortic involvement than patients with classic AD (60.3% versus
35.3%; P  0.001). Patients with IMH described more severe initial pain
than those with classic AD. Patients with IMH, however, were less likely to
have pulse deficits, ischemic leg pain, or aortic valvular insufficiency. Overall,
mortality of IMH was similar to AD (20.7% versus 23.9%; P  0.57).
Mortality of patients with IMH of the descending aorta was 8.3% versus
13.1% of patients with AD of the descending aorta (P 0.60). Mortality of
patients with IMHof the ascending aorta was 39.1% versus 29.9% of patients
with classic AD of the ascending aorta; P 0.34. Sixteen percent of patients
with an initial diagnosis of IMH progressed to AD on serial imaging studies.
Comment: The natural history of acute IMH of the aorta as well as its
prevalence is difficult to determine. The current study suggests that the
prevalence of IMH in patients with non-traumatic acute aortic syndromes is
about 6%. This is lower than previously reported. Overall, however, this
study, and others suggest, that despite the more limited aortic involvement
of IMH and the absence of true dissection flaps at initial presentation, the
overall natural history of the disease is similar to that of classic AD. At this
point the known natural history of IMH suggests treatment and follow up
should be similar to AD.
Engineering of fibrin-based functional and implantable small-diameter
blood vessels
Swartz DD, Russell JA, Andreadis ST. Am J Physiol Heart Circ Physiol
2005;288:H1451-60.
Conclusion: Fibrin can serve as an appropriate scaffold for engineering
small caliber blood vessels that have both vasoreactivity and considerable
mechanical strength.
Summary: Currently, autogenous tissue, such as saphenous vein or
radial artery, is the gold standard for an arterial substitute for a small caliber
vessel. The authors engineered implantable small diameter blood vessels
using a fibrin gel with embedded ovin smooth muscle and endothelial cells.
Fibrin gels can achieve high seeding of smooth muscle and endothelial cells
with uniform cellular distribution. Fibrin might thus be an alternative to
collagen as a scaffold for an engineered small caliber vessel.
The fibrin matrix based tissue engineered vessels developed in this
study exhibited considerable reactivity in response to both receptor and
non-receptor mediated dilators and vasoconstrictors. Apoprotinin when
added to fibrin gel preparation at moderate concentrations increased me-
chanical strength of the engineered blood vessel but decreased vascular
activity. Mechanical strength and reactivity of the blood vessels were com-
parable to those of native veins. The mechanical strength of the fibrin-based
blood vessels was sufficiently strong to withstand implantation into the
jugular veins of lambs. Late microscopic analysis indicated tissue engineered
vessels integrated well to native tissue while demonstrating similar flow rates
and patency as native vessels. At fifteen weeks after implantation the fibrin-
based vessels demonstrated matrix remodeling with production of both
elastin and collagen fibers and orientation of smooth muscle cells perpen-
dicular to the direction of blood flow.
Comment: One of the “Holy Grails” of vascular surgery is the devel-
opment of a commercially available, off the shelf, highly effective arterial
substitute for a small caliber vessel. This study indicates that use of a fibrin
scaffold for development of such an arterial substitute is a potentially fertile
line of inquiry. These engineered vessels appear to remain patent when
implanted, seamlessly integrate into native vessel, and display vaso-reactivity
similar to normal veins. Obviously, development of a commercial product is
many years away. Nevertheless, it is good to know that, even after the failure
of endothelial seeding of prosthetic grafts, investigators are still pursuing the
development of a small caliber arterial substitute.
High rate of early restenosis after carotid eversion endarterectomy in
homozygous carriers of the normal mannitose-binding lectin genotype
Rugonfalvi-Kiss S, Dosa E, Madsen HO. Stroke 2005;36:944-8.
Conclusion: Restenosis after carotid endarterectomy is partially genet-
ically determined.
Summary: Mannos-Binding Lectin (MBL) is a serum protein derived
from the liver. MBL participates in activating the lectin pathway of compli-
ment. Human MBL is coded on a single gene on Chromosome 10. Muta-
tions associated with this gene can cause low serum levels of MBL. There are
three known mutation variants and each reduces the functional MBL
subunits in heterozygous individuals by 5 to 10-fold. MBL appears to have
both protective and adverse affects in cardiovascular disease. Lack of func-
tional alleles is associated with coronary artery disease and increased carotid
plaque formation. However, the Lectin pathway of compliment may also
initiate the inflammatory reaction seen with ischemia reperfusion injury.
Participation of MBL in this inflammatory reaction suggests a possible
mechanism of MBL alleles in restenosis following carotid endarterectomy.
Patients in this study were derived from 123 patients who underwent
carotid endarterectomy and were followed by carotid duplex scanning for 14
months. An eversion technique of endarterectomy was employed in this
study. The authors then retrospectively examined 17 patients with carotid
restenosis following carotid endarterectomy (restenosis defined as greater
than 50% stenosis) and 29 patients without carotid restenosis after 29
months. In both groups, MBL genotypes were analyzed by polymerase
chain reaction based methods. MBL serum concentrations were also mea-
sured.
Compared to values measured six weeks after surgery, the degree of
stenosis suggested by carotid duplex scanning 14 months after surgery was
significantly higher in patients homozygous for the normal MBL genotype
(P  0.001). There was only a slight increase in levels of carotid duplex
determined stenosis at 14 months compared to 16 months in patients
carrying MBL variant alleles. Differences were more pronounced in females
than males. There was a significant increase in the frequency of MBL variant
genotypes in patients not experiencing restenosis compared to the patients
with restenosis (P  0.007).
Comment: The data indicate that a variant genotype compared to a
normal genotype for MBL, may protective with respect to development of
carotid restenosis. The pathophysiologic mechanisms underlying the MBL
genotype and carotid restenosis are unknown. In addition, the data make it
difficult to completely separate the gender effect. Overall, there may be a
complicated interplay between genetic and hormonal factors in develop-
ment of carotid restenosis.
Acute aortic dissection presenting with primarily abdominal pain: A
rare manifestation of a deadly disease
Upchurch GR, Nienaber C, Fattori R, et al. Ann Vasc Surg 2005;19:367-3.
Conclusion: There is increased mortality in patients with acute tho-
racic aortic dissection who present primarily with abdominal pain.
Summary: Classically, thoracic dissection presents with acute, severe
tearing back pain. Other presentations of thoracic dissection are, however,
possible. Some patients present primarily with abdominal pain. In this study,
992 patients, mean age 62.1 years  14.1 years; 68% male, were identified
with acute thoracic dissection from 1996 to 2001 from the International
Registry of Acute Aortic Dissection. Patients were analyzed for presenting
symptoms, demographics, signs of aortic dissection, ultimately determined
aortic pathology, and mortality. Patients were divided into two groups:
those presenting primarily with abdominal pain (Group 1, 46 patients, 4.6%)
and all other presentations (Group 2). The two groups had similar demo-
graphics. Sixty-three percent of patients in Group 1 presented with hyper-
tension compared to 47% of patients in Group 2 (P  0.04). Group 1
patients were less likely to present with evidence of end-organ malfunction.
Specifically following surgery for Type B dissection, mortality was increased
in patients presenting primarily with abdominal pain (28%) versus those not
presenting primarily with abdominal pain (10.2%), P  0.02.
Comment: The study indicates a high mortality rate in patients with
thoracic aortic dissection who present primarily with abdominal pain. Even
in the absence of back pain one should consider thoracic aortic dissection as
an etiology for abdominal pain in patients with appropriate risk factors for
dissection.
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